Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Clasificación en acciones #25700
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Precio por acción
$2.09
Última sincronización: 2022-03-21
Capitalización bursátil
$47.04M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
US
Comercio Recro Pharma, Inc. (REPH)

Categoría

Historial del precio de la acción de Recro Pharma, Inc. (REPH)
Precio más alto de cierre: $1.92 el 2022-03-01

Precio más bajo de cierre: $8.10 el 2014-03-01
Historial del precio de la acción de Recro Pharma, Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2022 23.15%
2021 -43.90%
2020 -83.97%
2019 139.49%
2018 -25.26%
2017 33.81%
2016 -16.69%
2015 218.14%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$163.75 27.60%
DE
$37.48 22.66%
JP
$220.05 30.36%
CH
$21.01 11.83%
IN